Back
Akero Therapeutics Vs. Fundamental Global Industry Stock Comparison
Sell
46
AKRO
Akero Therapeutics
Last Price:
28.09
Seasonality Move:
15.57%
Buy
60
FGF
Fundamental Global
Last Price:
31.12
Seasonality Move:
1.83%
Sell
46
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $28.09. The Score for AKRO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Fundamental Global (FGF)
is a Buy
Is Fundamental Global a Buy, Sell or Hold?
- The current Fundamental Global [FGF] share price is $31.01. The Score for FGF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- FGF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $28.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
FGF Stock Price Chart
What is Fundamental Global's stock price today?
-
The Fundamental Global share price today is $31.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGF is experiencing slight buying pressure.
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 38.58 | Sell |
Chaikin Money Flow: | -326572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.24 - 33) | Sell |
Bollinger Bands (100): | (24.58 - 30.28) | Buy |
FGF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.1 | Buy |
Relative Strength Index (14 RSI): | 66.15 | Buy |
Chaikin Money Flow: | 34089 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0 - 20.58) | Buy |
Bollinger Bands (100): | (-3.22 - 9.84) | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.35 | Sell |
20-day SMA: | 31.31 | Sell |
50-day SMA: | 29.37 | Sell |
200-day SMA: | 25.06 | Buy |
8-day EMA: | 31.07 | Sell |
20-day EMA: | 31.16 | Sell |
50-day EMA: | 29.69 | Sell |
200-day EMA: | 27.1 | Buy |
FGF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.6 | Buy |
20-day SMA: | 12.61 | Buy |
50-day SMA: | 5.63 | Buy |
200-day SMA: | 2.3 | Buy |
8-day EMA: | 21.92 | Buy |
20-day EMA: | 15.14 | Buy |
50-day EMA: | 8.49 | Buy |
200-day EMA: | 3.34 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.10 per share, and a decrease next year of $0.68 per share.
Fundamental Global Earnings Growth & FGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fundamental Global Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |